bioRxivCell BiologyPreprint
Naked antisense oligonucleotides access the cytosol during early endocytic trafficking
E SitarskaiD, Anand SaminathaniD, Gustavo ScanavachiiD, Elliott SomervilleiD, Margo CourtneyiD, Dylan A. ReidiD, Mathias Bogetoft DanielseniD, Fie Kristine Noergaard DavidseniD, Knud J. JenseniD, Frank C. Bennett, Tomas L. KirchhauseniD
Abstract
Phosphorothioate-modified antisense oligonucleotides (ASOs) enter cells, but their site of productive escape remains uncertain. We combined live-cell imaging and ratiometric pH measurements to follow a Malat1-targeting ASO internalized without a delivery vehicle. In U2OS cells, less than 4% of internalized ASO reached the nucleus under conditions that reduced Malat1 RNA by >90%. Most ASO accumulated in late endosomes, endolysosomes and lysosomes as foci and broadly distributed luminal signal. These compartments underwent neutralization without detectable membrane rupture or galectin-3 recruitment. ASO foci showed constrained motion, consistent with association with endolysosomal constituents. L-leucyl-L-leucine methyl ester-induced membrane damage or Calcium dependent lysosome exocytosis released dextran while retaining luminal ASO. Loss of the stress-granule scaffolding proteins G3BP1/2 modestly enhanced ASO activity without detectable endolysosomal damage. Tantalosin, a small molecule that perturbs endosomal recycling, redistributed the ESCRT-III protein IST1 to endosomes. It enhanced early escape of SYTOX Green and ASOs, detected by nuclear accumulation, and increased Malat1 knockdown, with cell-type-dependent responses. Tantalosin did not detectably increase nuclear ASO accumulation after sequestration in late compartments. These findings place productive ASO escape early in endocytic trafficking, most likely in early or recycling endosomes, before sequestration in largely nonproductive late compartments.
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- EPHA2 and scavenger receptor-directed trafficking enhances endosomal leakiness and antisense therapy delivery
Sergi Marco, Peter J. Walsh, … Jim C. Norman·bioRxiv·Feb 5, 2025
- A CRISPR/Cas9 screen reveals proteins at the endosome-Golgi interface that modulate cellular ASO activity
Liza Malong, Jessica Roskosch, … Filip Roudnicky·Nature CommunicationsPeer-reviewed·Jun 30, 2025
- A Genome-wide CRISPR screen unveils the endosomal maturation protein WDR91 as a promoter of productive ASO activity in melanoma
Grégory Menchon, Aris Gaci, … Rémy Pedeux·Molecular Therapy — Nucleic AcidsPeer-reviewed·May 24, 2025
- Lipid-ASO therapeutics exhibit differential tissue targeted delivery upon systemic or local CNS administration
Samantha Roudi, Hernando Yesid Estupiñan, … Samir EL Andaloussi·bioRxiv·Sep 2, 2026
- Reversable Acute Sedation Response of Phosphorothioate Antisense Oligonucleotides Following Local Delivery to the Central Nervous System
Jacqueline G. O’Rourke, Gemma Bachmann, … Holly B. Kordasiewicz·bioRxiv·Feb 13, 2025
- mTOR inhibition enhances delivery and activity of antisense oligonucleotides in uveal melanoma cells
S. Dewaele, L. Delhaye, … P. Mestdagh·bioRxiv·Sep 29, 2021